World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Chemistry 51 13892 12505 2155 2137 292 9881

Peng Zhan publications per year

The chart shows the history of publications by Peng Zhan between 2005 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Peng Zhan published across 21 years, from 2005 to 2025, averaging 17.7 papers a year. Output peaked at 42 publications in 2025. 76 of the 371 publications appeared in the last two years.

No. of publications
10 20 30 40
Bar chart. Horizontal axis: year, 2005 to 2025. Vertical axis: number of publications, 0 to 42. Peak 42 publications in 2025. 2005: 1 publication 2006: 0 publications 2007: 0 publications 2008: 3 publications 2009: 8 publications 2010: 8 publications 2011: 9 publications 2012: 19 publications 2013: 16 publications 2014: 15 publications 2015: 16 publications 2016: 18 publications 2017: 14 publications 2018: 19 publications 2019: 28 publications 2020: 25 publications 2021: 37 publications 2022: 22 publications 2023: 37 publications 2024: 34 publications 2025: 42 publications
2005 2025

371 publications in total across all disciplines

View publications per year as a table
Peng Zhan: publications per year, 2005 to 2025
Year Publications
2005 1
2006 0
2007 0
2008 3
2009 8
2010 8
2011 9
2012 19
2013 16
2014 15
2015 16
2016 18
2017 14
2018 19
2019 28
2020 25
2021 37
2022 22
2023 37
2024 34
2025 42
Total 371
Download as CSV

Peng Zhan publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Peng Zhan sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 63 bars. Horizontal axis: publications, 61–80 to 1,295+. Vertical axis: number of scientists, 0 to 1,350. Most scientists, 1,350, have 161–180 publications. The last bar groups every scientist with 1,295 publications or more. The highlighted bar, 281–300 publications, is where this scientist sits. 61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61–80 publications 1,295+

This scientist: 292 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

View publications distribution as a table
Number of Chemistry scientists by publication count, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
Publications Scientists This scientist
61–80 66
81–100 302
101–120 623
121–140 918
141–160 1,218
161–180 1,350
181–200 1,344
201–220 1,281
221–240 1,216
241–260 1,100
261–280 979
281–300 939 292
301–320 764
321–340 643
341–360 628
361–380 522
381–400 459
401–420 397
421–440 327
441–460 270
461–480 265
481–500 252
501–520 201
521–540 185
541–560 148
561–580 148
581–600 132
601–620 114
621–640 104
641–660 91
661–680 92
681–700 73
701–720 57
721–740 54
741–760 67
761–780 45
781–800 46
801–820 39
821–840 32
841–860 36
861–880 29
881–900 26
901–920 24
921–940 14
941–960 23
961–980 28
981–1,000 15
1,001–1,020 29
1,021–1,040 12
1,041–1,060 19
1,061–1,080 12
1,081–1,100 6
1,101–1,120 8
1,121–1,140 12
1,141–1,160 5
1,161–1,180 6
1,181–1,200 14
1,201–1,220 7
1,221–1,240 2
1,241–1,260 6
1,261–1,280 4
1,281–1,294 6
1,295+ 100
Download as CSV

Peng Zhan D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Peng Zhan sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 61 bars. Horizontal axis: D-Index, 40–41 to 159+. Vertical axis: number of scientists, 0 to 1,051. Most scientists, 1,051, have 56–57 D-Index. The last bar groups every scientist with 159 D-Index or more. The highlighted bar, 50–51 D-Index, is where this scientist sits. 40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40–41 D-Index 159+

This scientist: 51 D-Index — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

View D-Index distribution as a table
Number of Chemistry scientists by D-index, Research.com 2026 ranking edition. Based on 17,934 ranked scientists.
D-Index Scientists This scientist
40–41 289
42–43 612
44–45 808
46–47 776
48–49 835
50–51 861 51
52–53 872
54–55 933
56–57 1,051
58–59 930
60–61 882
62–63 834
64–65 731
66–67 775
68–69 683
70–71 646
72–73 561
74–75 501
76–77 437
78–79 388
80–81 354
82–83 292
84–85 275
86–87 254
88–89 235
90–91 185
92–93 192
94–95 155
96–97 163
98–99 125
100–101 105
102–103 105
104–105 112
106–107 88
108–109 68
110–111 69
112–113 65
114–115 79
116–117 61
118–119 44
120–121 37
122–123 40
124–125 33
126–127 26
128–129 34
130–131 35
132–133 25
134–135 27
136–137 17
138–139 16
140–141 20
142–143 20
144–145 15
146–147 9
148–149 9
150–151 16
152–153 11
154–155 9
156–157 3
158 3
159+ 98
Download as CSV

Overview

Peng Zhan is affiliated with Shandong University in China, contributing extensively to research in medicine and biochemistry, genetics, and molecular biology. Their work spans several key subfields, including infectious diseases, molecular biology, virology, epidemiology, and organic chemistry.

The primary research topics addressed by Peng Zhan include:

  • HIV/AIDS drug development and treatment
  • HIV research and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Computational drug discovery methods
  • Click chemistry and applications
  • Hepatitis C virus research
  • SARS-CoV-2 and COVID-19 research

Peng Zhan has published numerous papers in well-known scientific venues. Frequent publication venues encompass:

  • Journal of Medicinal Chemistry (35 publications)
  • European Journal of Medicinal Chemistry (23 publications)
  • Chinese Chemical Letters (11 publications)
  • Drug Discovery Today (6 publications)
  • Bioorganic & Medicinal Chemistry (6 publications)

Among recent papers authored or co-authored by Peng Zhan are:

  • "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling," 2020, Signal Transduction and Targeted Therapy
  • "Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities," 2020, Journal of Medicinal Chemistry
  • "Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses," 2021, Chemical Society Reviews
  • "SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules," 2022, Signal Transduction and Targeted Therapy
  • "Recent developments in the medicinal chemistry of single boron atom-containing compounds," 2021, Acta Pharmaceutica Sinica B

Peng Zhan frequently collaborates with several co-authors in their field, including:

  • Xinyong Liu
  • Dongwei Kang
  • Christophe Pannecouque
  • Erik De Clercq
  • Shujing Xu

In addition to journal publications, Peng Zhan has contributed to book publications. Notably, a title published by Springer Nature is "Antiviral Drug Discovery and Development" (2021), which has received citations.

Best Publications

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

    Peng Zhan;Christophe Pannecouque;Erik De Clercq;Xinyong Liu

  • Conformational restriction: an effective tactic in 'follow-on'-based drug discovery

    Zengjun Fang;Yu'ning Song;Peng Zhan;Qingzhu Zhang

  • 8-Hydroxyquinoline: a privileged structure with a broad-ranging pharmacological potential

    Yu'ning Song;Hao Xu;Wenmin Chen;Peng Zhan

  • Recent applications of click chemistry in drug discovery.

    Xiangyi Jiang;Xia Hao;Lanlan Jing;Gaochan Wu

  • Current drug research on PEGylation with small molecular agents

    Wenjun Li;Peng Zhan;Erik De Clercq;Hongxiang Lou

  • Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.

    Siyu Xiu;Alexej Dick;Han Ju;Sako Mirzaie

  • Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries.

    Xueshun Wang;Boshi Huang;Xinyong Liu;Peng Zhan

  • The Journey of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) from Lab to Clinic

    Vigneshwaran Namasivayam;Murugesan Vanangamudi;Victor G. Kramer;Sonali Kurup

  • Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.

    Dongwei Kang;Zengjun Fang;Zhenyu Li;Boshi Huang

  • Overview of Recent Strategic Advances in Medicinal Chemistry

    Gaochan Wu;Tong Zhao;Dongwei Kang;Jian Zhang

  • Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms

    Dongyue Li;Peng Zhan;Erik De Clercq;Xinyong Liu

  • Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses

    Yue Ma;Estrella Frutos-Beltrán;Dongwei Kang;Christophe Pannecouque

  • 1,3,4-Oxadiazole: A Privileged Structure in Antiviral Agents

    Z. Li;P. Zhan;X. Liu

  • Recent advances in DAPYs and related analogues as HIV-1 NNRTIs.

    Xuwang Chen;Peng Zhan;Dongyue Li;Erik De Clercq

  • Design Strategies of Novel NNRTIs to Overcome Drug Resistance

    Peng Zhan;Xinyong Liu;Zhenyu Li;Christophe Pannecouque

  • Recent developments in the medicinal chemistry of single boron atom-containing compounds

    Shu Song;Ping Gao;Lin Sun;Dongwei Kang

  • Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants

    Dongwei Kang;Zengjun Fang;Boshi Huang;Xueyi Lu

  • Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: Optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches

    Boshi Huang;Cuicui Li;Wenmin Chen;Tao Liu

  • Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies

    Peng Zhan;Xinyong Liu;Zhenyu Li;Zengjun Fang

  • Identification of the KDM2/7 histone lysine demethylase subfamily inhibitor and its antiproliferative activity.

    Takayoshi Suzuki;Hiroki Ozasa;Yukihiro Itoh;Peng Zhan

  • Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.

    Ye Tian;Zhaoqiang Liu;Jinghan Liu;Boshi Huang

  • Fused heterocyclic compounds bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 1: Design, synthesis and biological evaluation of novel 5,7-disubstituted pyrazolo[1,5-a]pyrimidine derivatives

    Ye Tian;Deping Du;Diwakar Rai;Liu Wang

  • Identification of Highly Selective and Potent Histone Deacetylase 3 Inhibitors Using Click Chemistry-Based Combinatorial Fragment Assembly

    Takayoshi Suzuki;Takayoshi Suzuki;Yuki Kasuya;Yukihiro Itoh;Yosuke Ota

  • Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-Typed HIV-1 NNRTIs against Wild-Type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles.

    Boshi Huang;Wenmin Chen;Tong Zhao;Zhenyu Li

  • 1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.

    Peng Zhan;Xinyong Liu;Yuan Cao;Yan Wang

Frequent Co-Authors

Xinyong Liu
Xinyong Liu Shandong University
Erik De Clercq
Erik De Clercq Rega Institute for Medical Research
Christophe Pannecouque
Christophe Pannecouque Rega Institute for Medical Research
Jan Balzarini
Jan Balzarini KU Leuven
Luis Menéndez-Arias
Luis Menéndez-Arias Spanish National Research Council
Takayoshi Suzuki
Takayoshi Suzuki Osaka University
Chin Ho Chen
Chin Ho Chen Duke University
Kuo Hsiung Lee
Kuo Hsiung Lee University of Minnesota
Hong Liu
Hong Liu Shandong University
Jacob Kongsted
Jacob Kongsted University of Southern Denmark

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various innovative and impactful career paths, many of which intersect with forensic science and criminal justice. For those interested in hands-on technical roles, becoming an autopsy technician is a specialized option involving the preparation and analysis of medical examiner cases.

Many students choose to advance their knowledge through a forensic degree online, combining chemistry with criminal investigation techniques. These programs offer flexibility and affordability, making it easier to gain relevant expertise without interrupting your career.

For those aiming to delve deeper into the psychological aspects of forensics, pursuing a masters in forensic psychology online can enhance your understanding of human behavior and improve your analytical skills, which are crucial in many forensic careers.

Career prospects in forensic science remain promising, with competitive compensation for qualified professionals. Exploring the forensic scientist salary and job outlook can help you make informed decisions about your educational path and career goals in this dynamic field.

Best Scientists Citing Peng Zhan

Trending Scientists

Recently Published Articles